ALK and neoplasm: Here genetically engineered mouse models (GEMMs) models [64, 65, 66], and patient-derived xenografts (PDXs) [67] of KRAS, EGFR, and EML-ALK-driven tumours have been instrumental in understanding the key aspects of NSCLC biology.